“Tailgating” vexes Brigham and Women’
For several days, a middle-aged woman who claimed to be a doctor in training roamed the halls of Brigham and Women’s Hospital in Boston, dressed in scrubs, asking questions at a lecture, attending patient rounds, and observing surgical procedures, according to a report in the Boston Globe.
A former surgical resident who had been dismissed from a program in New York City, Cheryl Wang, 42, blended in with the circulating mass of medical personnel, slipping into restricted areas and suggesting she had connections to an attending doctor.
The woman’s ability to enter restricted operating room suites without an identification badge shows how difficult it can be to enforce security in institutions that teem with thousands of patients, families, and staff each day, according to the article.
The incident also highlights a security problem called “tailgating.” As is the practice at many hospitals, Brigham operating room staff members hold their identification badges in front of an electronic card reader to gain access to surgery suites. According to video surveillance and staff accounts, the woman tagged along behind employees during shift changes, slipping in as groups of operating room staff held the door for one another.
The hospital told the Globe that it has strengthened its policy for allowing observers into its 47 operating rooms. Physicians sponsoring a visitor are now required to verify with a student’s educational institution that the student “is in good standing’’—a safety step that wasn’t taken in Wang’s case. The hospital said it also plans to educate staff about the dangers of tailgating.
Nurses have complained about security at Brigham in the past. The issue flared two years ago, when Dr. Michael Davidson was fatally shot by a man who was distraught over the death of his elderly mother, who was a patient. At the time, nurses said that it was too easy to access patient floors and that they did not have enough input on security decisions.
Source: Boston Globe;(link is external) February 5, 2017.
Avedis Donabedian, MD
The measures most often used today to assess care quality are process measures. Actual outcomes, of course, are harder to measure than whether a certain action has been taken—checking the feet of a patient with diabetes, for example. But many experts don’t think process measures get at the heart of quality.
FiercePharma has compiled a list of the top 15 cancer medications that are expected to dominate the oncology market in 2022.
The problem, say hospitals and some analysts, is that rating hospital quality is not so straightforward. How a hospital delivers care is multifactorial and complex, they argue, so trying to cram that into a single score is misleading and can end up like rating a restaurant on its parking.
Matthew Hamilton, MD
Immunotherapy causes the body to attack cancer, but it doesn’t stop there in some cases. It also turns on healthy tissue in the pancreas, kidneys, bowel, liver, lungs, and heart. These are life-threatening developments that force physicians to weigh the benefits of these “miracle drugs.”
Nt’l Pharmaceutical Council
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.